-
公开(公告)号:US20170304442A1
公开(公告)日:2017-10-26
申请号:US15330956
申请日:2015-04-14
发明人: Heyue Zhou , Gunnar F. Kaufmann
IPC分类号: A61K39/395 , C07K16/30
CPC分类号: A61K39/39558 , A61K39/3955 , C07K16/22 , C07K16/30 , C07K2317/21 , C07K2317/33 , C07K2317/34 , C07K2317/92
摘要: There is disclosed compositions and methods relating to or derived from anti-WISP1 antibodies. More specifically, there is disclosed fully human antibodies that bind WISP1, WISP1-binding fragments and derivatives of such antibodies, and WISP1 binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having WISP1 related disorders or conditions. There is also disclosed a method for treating or preventing various cancers or inflammatory diseases and various diseases of the heart, bone/joints or lung.
-
公开(公告)号:US20160326266A1
公开(公告)日:2016-11-10
申请号:US14708273
申请日:2015-05-10
发明人: Yanwen Fu , Gunnar F. Kaufmann , Bryan Jones , Rahaleh Toughiri
IPC分类号: C07K16/46
CPC分类号: C07K16/468 , A61K47/6881 , A61K47/6889 , C07K16/00 , C07K2317/14 , C07K2317/31 , C07K2317/53
摘要: There is disclosed a process for forming chemically-locked bispecific or heterodimer antibodies, preferably in the IgG class, in high specificity and with high homogeneity. More specifically, there is disclosed a chemically-locked bispecific IgG class antibody having a linkage region joined together with bio-orthogonal click chemistry.
摘要翻译: 公开了以高特异性和高均匀性形成化学上锁定的双特异性或异二聚体抗体的方法,优选在IgG类中。 更具体地,公开了具有与生物正交点击化学结合在一起的连锁区域的化学锁定双特异性IgG类抗体。
-
公开(公告)号:US20220363758A1
公开(公告)日:2022-11-17
申请号:US17622087
申请日:2020-06-30
发明人: Xiao He , Yanliang Zhang , Yun Wei Lai , Gunnar F. Kaufmann , Barbara A. Swanson , Lisa Diane Kerwin , Susan M. Richards
摘要: The present disclosure provides heterodimeric antibodies that bind to two different target antigens at the same time. In one embodiment, the heterodimeric antibodies are bispecific antibodies. In one embodiment, the heterodimeric antibodies comprise three polypeptides including: a first polypeptide comprising an scFv-Fc fusion polypeptide; a second polypeptide comprising an immunoglobulin heavy chain; and a third polypeptide comprising an immunoglobulin light chain. In one embodiment, the first polypeptide includes one or more point mutations that confer increased thermal-stability to the first polypeptide.
-
公开(公告)号:US20220324974A1
公开(公告)日:2022-10-13
申请号:US17602908
申请日:2020-04-10
发明人: Yanliang Zhang , Gunnar F. Kaufmann , Xiao He , Yun Wei Lai
IPC分类号: C07K16/28
摘要: The present disclosure provides several embodiments of multi-specific antigen binding protein complexes. In some embodiments, the multi-specific antigen binding protein complex is composed of either two or three polypeptide chains that assemble with each other to form het-erodimeric complexes comprising two different Fab regions each capable of binding two different epitopes and comprising an Fc region which is capable of exhibiting Fc effector function, thus having a relatively simple structure compared to certain other multi-specific antibodies. In one embodiment, the multi-specific antigen binding protein complex is activatable as one of the polypeptide chains that compose the protein complex carries a cleavable linker.
-
公开(公告)号:US20220242954A1
公开(公告)日:2022-08-04
申请号:US17554926
申请日:2021-12-17
IPC分类号: C07K16/28
摘要: There is disclosed compositions and methods relating to or derived from anti-PD-1 antibodies. More specifically, there is disclosed fully human antibodies that bind PD-1, PD-1-binding fragments and derivatives of such antibodies, and PD-1-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having PD-1 related disorders or conditions, including various inflammatory disorders and various cancers.
-
公开(公告)号:US11267905B2
公开(公告)日:2022-03-08
申请号:US16388760
申请日:2019-04-18
摘要: Provided are bispecific antibody compounds having the Formula I: wherein, FAB1, FAB2, and —X— are as defined herein. The provided bispecific antibody compounds can be used a modulators of target molecules, including CD3, PSMA, CD19, CXCR5, CD33, PDL1, VEGFR2, cMet, or Ax1, and are useful in the treatment of one or more conditions.
-
公开(公告)号:US11242391B2
公开(公告)日:2022-02-08
申请号:US16742712
申请日:2020-01-14
IPC分类号: C07K16/28 , A61K39/395 , A61P35/00
摘要: There is disclosed compositions and methods relating to or derived from anti-PD-1 antibodies. More specifically, there is disclosed fully human antibodies that bind PD-1, PD-1-binding fragments and derivatives of such antibodies, and PD-1-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having PD-1 related disorders or conditions, including various inflammatory disorders and various cancers.
-
公开(公告)号:US20210130468A1
公开(公告)日:2021-05-06
申请号:US16742712
申请日:2020-01-14
IPC分类号: C07K16/28
摘要: There is disclosed compositions and methods relating to or derived from anti-PD-1 antibodies. More specifically, there is disclosed fully human antibodies that bind PD-1, PD-1-binding fragments and derivatives of such antibodies, and PD-1-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having PD-1 related disorders or conditions, including various inflammatory disorders and various cancers.
-
公开(公告)号:US20210052738A1
公开(公告)日:2021-02-25
申请号:US17008432
申请日:2020-08-31
发明人: James T. Patterson , Gunnar F. Kaufmann , Yanwen Fu , Tong Zhu
摘要: Provided are bispecific conjugates having the general formula: pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and their use in the treatment of cancer.
-
公开(公告)号:US20190248923A1
公开(公告)日:2019-08-15
申请号:US16388760
申请日:2019-04-18
CPC分类号: C07K16/468 , C07K16/2803 , C07K16/2809 , C07K16/2827 , C07K16/2863 , C07K16/30 , C07K16/3069 , C07K2317/31 , C07K2317/55 , C07K2317/56 , C07K2317/73 , C07K2317/92
摘要: Provided are bispecific antibody compounds having the Formula I: wherein, FAB1, FAB2, and —X— are as defined herein. The provided bispecific antibody compounds can be used a modulators of target molecules, including CD3, PSMA, CD19, CXCR5, CD33, PDL1, VEGFR2, cMet, or Ax1, and are useful in the treatment of one or more conditions.
-
-
-
-
-
-
-
-
-